|
Wockhardt is a global, pharmaceutical and biotechnology company that has grown by leveraging two powerful trends impacting the world of medicine - globalisation and biotechnology.
The Company has a market capitalisation of US$ 1.3 billion and an annual turnover of US$ 285 million (Rs. 12.39 billion). Wockhardt's pace of growth and momentum permeates every mindset, system and technology within the organisation. Wockhardt today, is distinguished by a strong and growing presence in the world's leading markets, with half of its revenue coming from Europe and the United States. Wockhardt's market presence covers formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients (APIs). Wockhardt's manufacturing facilities in India and UK have the approval of major regulatory bodies, including US FDA and UK's MHRA, with capabilities for both Finished Dosage Formulations and APIs. The output includes Steriles (Injectables), Biopharmaceuticals, Orals (Tablets & Liquids), Topicals (Creams & Ointments).
|
